Is IQVIA Holdings (IQV) Undervalued As Earnings Growth Anchors A $227 Fair Value?
IQVIA Holdings (IQV) has recently drawn investor attention after fresh performance data showed double digit gains over the past month and past 3 months, alongside mixed longer term total returns and ongoing revenue and net income growth.
See our latest analysis for IQVIA Holdings.
Over the past year, IQVIA Holdings has paired a 30.36% 1 year total shareholder return with a 1 month share price return of 15.93% and a 3 month share price return of 20.27%. However, longer 3 and 5 year total shareholder returns remain in decline, which suggests recent momentum is building from a weaker long term base and may reflect changing views on its growth prospects and risk profile at the current US$206.81 share price.
If IQVIA Holdings has you looking closer at healthcare data and clinical research, it could be worth scanning a wider set of healthcare AI opportunities through the 40 healthcare AI stocks
After a sharp move higher and a mixed longer term track record, the real choice with IQVIA Holdings is whether to accept today’s US$206.81 price or hold out for a different entry. So how does the current valuation stack up?
Most Popular Narrative: 8.9% Undervalued
Compared with IQVIA Holdings' last close at $206.81, the most widely followed narrative pins fair value closer to the mid $220s, built on detailed growth and earnings assumptions.
Analysts expect earnings to reach $2.0 billion (and earnings per share of $12.31) by about June 2029, up from $1.4 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $2.5 billion.
Want to see what sits behind that earnings jump for IQVIA Holdings? The narrative leans on measured revenue growth, firmer margins, and a valuation multiple more often attached to quality compounders. Curious which specific assumptions bridge today’s profits to that future earnings profile and justify the implied fair value? The full narrative lays those numbers out in black and white.
Result: Fair Value of $226.95 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, IQVIA Holdings still faces CRO pricing pressure and high leverage. As a result, weaker margins or costlier refinancing could quickly challenge that 8.9% undervaluation story.
Find out about the key risks to this IQVIA Holdings narrative.
Next Steps
Uncertain whether recent enthusiasm around IQVIA Holdings really fits the balance of risks and rewards, or not? Act while the data is fresh and weigh both sides of the story for yourself by checking the 3 key rewards and 1 important warning sign
Looking for more investment ideas beyond IQVIA Holdings?
If IQVIA Holdings has sharpened your focus, do not stop here. Broaden your watchlist now so you are not late to the next opportunity.
- Target reliable cash generators by scanning companies with solid balance sheet and fundamentals stocks screener (48 results) built to handle tougher conditions.
- Hunt for potential upside by reviewing screener containing 20 high quality undiscovered gems that many investors may not be watching yet.
- Prioritise sleep-at-night holdings by checking 78 resilient stocks with low risk scores that aim to keep volatility in check.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com